ClinVar Miner

Submissions for variant NM_001104631.2(PDE4D):c.125C>A (p.Pro42Gln)

gnomAD frequency: 0.00013  dbSNP: rs372946517
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000388985 SCV000458007 benign Acrodysostosis 2 with or without hormone resistance 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000903518 SCV001047990 benign not provided 2024-01-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV002523528 SCV003645430 uncertain significance Inborn genetic diseases 2021-07-23 criteria provided, single submitter clinical testing The c.125C>A (p.P42Q) alteration is located in exon 1 (coding exon 1) of the PDE4D gene. This alteration results from a C to A substitution at nucleotide position 125, causing the proline (P) at amino acid position 42 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
GeneDx RCV000903518 SCV004028013 uncertain significance not provided 2023-02-20 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
PreventionGenetics, part of Exact Sciences RCV003932456 SCV004755247 likely benign PDE4D-related disorder 2023-12-20 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.